Cancer Types
& Treatment
Directions
& Facilities
Our
Team
Research
& Clinical Trials
TakeCharge!
Home
GO
Clinical Trials
Choosing to participate in a Clinical Trial is a very personal decision – and something you and your entire Moffitt care team can decide together.
Find a Researcher
Research Disciplines
Programs
Departments
Centers of Excellence
Working Groups
Clinical Trials
Clinical Trial Definitions
Informed Consent
Patient Protection
Ten Things to Know
Questions to Ask Your Doctor
Hematology Clinical Trials
Clinical Trials Video
Consortia and Co-Op Groups
Clinical Trials Administration
Research Cores & Technology
Current Research
Partnerships & Studies
ICARE
Ponce School of Medicine
Physical Science Oncology Center
Tampa Bay Community Center Network
M2Gen
Path to Commercialization
Business of Biotech
2013 Event Info
Registration
Department of Oncologic Sciences
Education & Training
Cancer Control Journal
Funding Opportunities
Events in Research
Clinical Trials
Where You Are:
Home
>
Research & Clinical Trials
>
Clinical Trials
Search Clinical Trials
BY CANCER
OR
BY DRUG
OR
STUDY TITLE
(KEYWORD)
(Optional) Show only results for open trials at:
Moffitt Only
Affiliates Only
Select Cancer Type
Anus
Leukemia, not otherwise specified
Other Hematopoietic
Any Site
Leukemia, other
Other Male Genital
Bladder
Lip, Oral Cavity and Pharynx
Other Respiratory and Intrathoracic Organs
Bones and Joints
Liver
Other Skin
Brain and Nervous System
Lung
Other Urinary
Breast - Female
Lymphoid Leukemia
Ovary
Breast - Male
Melanoma, skin
Pancreas
Cervix Uteri
Multiple Myeloma
Prostate
Colon
Mycosis Fungoides
Rectum
Corpus Uteri
Myeloid and Monocytic Leukemia
Small Intestine
Esophagus
Non-Hodgkin's Lymphoma
Soft Tissue
Eye and Orbit
Other Digestive Organ
Stomach
Hodgkin's Lymphoma
Other Endocrine System
Thyroid
Kidney
Other Female Genital
Unknown Sites
Larynx
Select Drug Type
177Lu-DOTA0-Ty3-Octreotate
Eltrombopag olamine
pasireotide LAR
18F-fluoromisonidazole
Erbitux
Pazopanib
1-Methyl-D-tryptophan
Eribulin Mesylate
PCI-32765
5-fluorouracil
everolimus
PCV13
ACE-011
Faslodex
PD 0332991
Ad.p53 DC
Fidaxomicin
Peg-asparaginase
Adcetris
FK228
Pemetrexed
Adriamycin
FK506
PF-04449913
AGS-003
Flavopiridol
Placebo
Aldesleukin
fludarabine
Plerixafor
Alimta
Fluticasone
PLX-4032
Alisertib
FOLFIRI
Poly IC-LC
Alkeran
FOLFOX
Pomalidomide
ALT-801
fulvestrant
Pralatrexate
AMD3100
Gardasil
prednisone
AMG 386
G-CSF
Procarbazine
AMG 655
gemcitabine
Proleukin
AP23573
Gemzar
PS-341
ARQ 197
GM.CD40L
Purified Isofavones/placebo
ARRY-614
GM.CD40L.CCL21
PV-10
AS15 ASCI
GM-CSF
PXD101
ATG
goserelin acetate
RAD001
ATRA
gp 100:209-217(210) Peptide
Rapamune
Autologous Dendritic Cells
gp 100:280-288 (288V) Peptide
Rapamycin
Avastin
GSK1120212
recMAGE-A3 + AS15 ASCI
axitinib
GSK2118436
recNY-ESO-1
AZD2171
GSK2241658A
Regorafenib
Azithromycin
Gw572016
Revlimid
BAY 43-9006
Ibritumomab tiuxetan
RGI-2001
BAY 73-4506
Idarubicin
Ridaforolimus
BAY 80-6946
IL-2
Rituxan
BCG
INCB024360
rituximab
Belinostat
Indoximod
RO5185426
Bevacizumab
In-epratuzumab
Romidepsin
Bexarotene
interferon alpha 2b
Ruxolitinib
BEZ235
Interleukin-2
SAHA
BKM120
IPI-504
sargramostatin
BMS-936558
Ipilimumab
SGN-35
BMS-936564
irinotecan
SGN-CD19A
BMS-982470
Jakafi
Sirolimus
BMS-986015
Jevtana
SOM230
Bortezomib
KB004
Sorafenib
Brentuximab vedotin
KPT-330
Sotatercept
busulfan
KW-0761
Standard of Care
BYM338
Lapatinib
suberoylanilide hydroxamic acid
Cabazitaxel
LCL 161
Sunitinib Malate
Cabozantinib
LDE225
Sylatron
Camptosar
lenalidomide
Tacrolimus
capecitabine
Leukine
Taxol
carboplatin
Leuprolide
Taxotere
CC-115
LGX818
Temodal
CC-223
Liposomal Cisplatin
Temozolomide
CC-4047
LY2228820
Temsirolimus
CC-5013
MART-1:26-35(27L) Peptide
TH-302
CCI-779
MDX-1106
TIL
Cediranib
MEDI4736
Tivantinib
Cetuximab
MEK162
TKI258
CH5424802
Melphalan
Topotecan
cisplatin
Metformin
Trabectedin
CPT-11
methotrexate
Trametinib
CPX-351
Methylprednisolone
Unconjugated Epratuzumab
CRS-207
mitoxantrone
US-ATG-F
Custirsen sodium
MK-1775
Ustekinumab/placebo
cyclophosphamide
MK-3475
V503
Cyclosporine
MK-8242
Valrubicin
Cytarabine
MK-8669
Valstar
Cytosine Arabinoside
MLN0264
Velban
cytoxan
Montanide ISA 51 VG
Velcade
dabrafenib
montelukast
Veliparib
Dacarbazine
MORAb-004
Veltuzamab
Dasatinib
Mozobil
Vemurafenib
Daunomycin
MPDL3280A
Vinblastine
daunorubicin
NeuVax
Vincristine
Decavac
Nilotinib
Vorinostat
decitabine
Nivolumab
Vosaroxin
Dexamethasone
Not Applicable
Xeloda
DN24-02
Novantrone
XL888
docetaxel
NY-ESO-1:157-165(165V) Peptide
Y-Epratuzumab Tetraxetan
Dovitinib
octreotide LAR
Yervoy
Doxil
Ofatumumab
Yondelis
doxorubicin
OSI-906
Zelboraf
doxorubicin liposome
Other
Zevados
DTIC
paclitaxel
Zoladex
E7080
Paraplatin
Zolinza
Eligard